🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Bladder › Oklahoma › Oklahoma City

Qorannoo klinikaalii Dukkana Bladder Oklahoma City, OK keessatti

Qorannoo 11 Dukkana Bladder f Oklahoma City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Vanguard Study: Testing a New Way to Screen for Cancer

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06995898

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Namoota walitti qabaa jiraSadarkaa 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06770582

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Mercy Hospital Oklahoma City, Oklahoma City
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Namoota walitti qabaa jiraSadarkaa 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Namoota walitti qabaa jiraSadarkaa 1
  • University of Oklahoma - Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Namoota walitti qabaa jiraSadarkaa 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07097142

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Namoota walitti qabaa jiraSadarkaa 2
  • OU Health Stephenson Cancer Center, Oklahoma City
  • OU Medical Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • OU Health University of Oklahoma Medical Center, Oklahoma City
  • Stephenson Cancer Center (chemo location), Oklahoma City
  • University of Oklahoma Health Science Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT04389632

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Mercy Hospital - OKC, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT07327489

Qorannoo Dukkana Bladder magaalota biroo keessatti

Qorannoo biroo Oklahoma City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.